# FDA Inspection 1169649 - Vitalant - May 04, 2022

Source: https://www.keypedia.com/records/fda_inspections/vitalant/cf12f21f-154e-4cba-a02c-a063dcbe779a
Source feed: FDA_Inspections

> FDA Inspection 1169649 for Vitalant on May 04, 2022. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1169649
- Company Name: Vitalant
- Inspection Date: 2022-05-04
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1169649 - 2022-05-04](https://www.keypedia.com/records/fda_inspections/vitalant/9e7623d7-4f82-4fc6-8f4a-6e84acab0427)
- [FDA Inspection 1033842 - 2017-11-09](https://www.keypedia.com/records/fda_inspections/vitalant/5d5d3c49-999b-4f2a-9ec2-bee7e2611023)
- [FDA Inspection 968737 - 2016-02-29](https://www.keypedia.com/records/fda_inspections/vitalant/e39c5c34-a7be-4987-a5e0-1b9c31f9f426)
- [FDA Inspection 860662 - 2013-12-27](https://www.keypedia.com/records/fda_inspections/vitalant/1af7a7db-efa2-425a-87fc-75953d2494a9)
- [FDA Inspection 755446 - 2011-11-21](https://www.keypedia.com/records/fda_inspections/vitalant/f4e69a6b-3b93-43ea-83d5-5578d5d7e67a)

Company: https://www.keypedia.com/companies/vitalant/1a0558f7-d17e-4154-9916-76840b874e54

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d